Indian Pharma Stocks: Cheap or Not

Indian Pharma is down in the dumps and does not see any hope for a turnaround around any time soon. However, analyzing the Pharma companies namely  we were intrigued to see the valuations from a price to book perspective.  Seeing a price to book ratio in FY 19 of around 2 for companies like Dr Reddy’s, Aurobindo Pharma, Lupin, Cipla and Glenmark make it interesting at some time in the future.  Continue reading “Indian Pharma Stocks: Cheap or Not”